WEBSITE BSE:506655 NSE : SUDARSH.CHEM 10 May, 16:01
Market Cap ₹4977 Cr.
Stock P/E 15.0
P/B 4.5
Current Price ₹719
Book Value ₹ 161.3
Face Value 2
52W High ₹781.5
Dividend Yield 0.21%
52W Low ₹ 382.1
Sudarshan Chemical Industries Ltd is a holding company. The Company is a colour and effect pigment producer. It operates via various segments, which consist of Pigments, Agro chemical compounds and Others. It's Pigments segment is engaged in the manufacturing of Green, Azos, Blue and High Performance Pigments, Effects, Pigment Preparations and Inorganics. The Agro chemical section offers merchandise, that are generic in nature. The Company elements pigments to inks, cosmetics, fabric, paints, plastics, and different programs. It produces quite a number of classical organic pigments for the colour of publications and commercial printing inks for magazines, direct mail and other business printing. The Company provides its pigments underneath numerous brands, including Sudadur, Sudafine, Sumicos, Prestige, Sudaperm, Sudafast, Sudacolor, and Sumica. Its pigments are exported to various markets in America, Asia and Europe. It has over manufacturing centres at Roha and Mahad in India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 498 | 602 | 627 | 554 | 528 | 528 | 691 | 608 | 601 | 566 |
Other Income | 1 | 3 | 2 | 1 | 1 | 1 | 2 | 4 | 6 | 4 |
Total Income | 499 | 605 | 629 | 555 | 530 | 529 | 693 | 612 | 606 | 570 |
Total Expenditure | 445 | 529 | 541 | 513 | 486 | 486 | 606 | 538 | 535 | 504 |
Operating Profit | 54 | 75 | 88 | 42 | 44 | 43 | 86 | 74 | 71 | 66 |
Interest | 4 | 5 | 5 | 6 | 9 | 11 | 15 | 10 | 10 | 9 |
Depreciation | 22 | 22 | 25 | 26 | 27 | 31 | 31 | 35 | 35 | 35 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 315 | 0 | 0 |
Profit Before Tax | 28 | 49 | 58 | 10 | 8 | 1 | 41 | 344 | 26 | 22 |
Provision for Tax | 5 | 12 | 13 | 3 | 3 | 0 | 8 | 77 | 8 | 7 |
Profit After Tax | 23 | 36 | 45 | 7 | 5 | 1 | 33 | 267 | 18 | 15 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 23 | 36 | 45 | 7 | 5 | 1 | 33 | 267 | 18 | 15 |
Adjusted Earnings Per Share | 3.3 | 5.3 | 6.5 | 1 | 0.7 | 0.1 | 4.7 | 38.6 | 2.6 | 2.1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 873 | 1119 | 1218 | 1409 | 1282 | 1329 | 1593 | 1708 | 1864 | 2201 | 2302 | 2466 |
Other Income | 7 | 4 | 24 | 14 | 18 | 11 | 7 | 5 | 17 | 5 | 5 | 16 |
Total Income | 880 | 1122 | 1242 | 1423 | 1300 | 1340 | 1600 | 1713 | 1881 | 2206 | 2307 | 2481 |
Total Expenditure | 793 | 987 | 1088 | 1240 | 1095 | 1142 | 1387 | 1460 | 1584 | 1923 | 2089 | 2183 |
Operating Profit | 87 | 135 | 154 | 184 | 205 | 198 | 213 | 253 | 297 | 283 | 218 | 297 |
Interest | 34 | 43 | 41 | 37 | 30 | 25 | 19 | 16 | 20 | 23 | 44 | 44 |
Depreciation | 26 | 37 | 42 | 48 | 49 | 58 | 66 | 74 | 87 | 89 | 114 | 136 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 72 | 17 | 0 | 0 | 0 | 315 |
Profit Before Tax | 26 | 55 | 72 | 99 | 126 | 115 | 201 | 180 | 190 | 171 | 60 | 433 |
Provision for Tax | 4 | 20 | 17 | 29 | 34 | 38 | 68 | 35 | 49 | 41 | 15 | 100 |
Profit After Tax | 22 | 35 | 54 | 70 | 92 | 77 | 133 | 145 | 141 | 130 | 45 | 333 |
Adjustments | 0 | 0 | 0 | 0 | 10 | 8 | 2 | -1 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 22 | 35 | 54 | 70 | 101 | 85 | 135 | 145 | 141 | 130 | 45 | 333 |
Adjusted Earnings Per Share | 3.2 | 5.1 | 7.9 | 10.1 | 14.6 | 12.2 | 19.5 | 20.9 | 20.4 | 18.8 | 6.5 | 48 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 5% | 10% | 12% | 10% |
Operating Profit CAGR | -23% | -5% | 2% | 10% |
PAT CAGR | -65% | -32% | -10% | 7% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 75% | 4% | 18% | 28% |
ROE Average | 5% | 14% | 19% | 19% |
ROCE Average | 6% | 12% | 16% | 16% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 254 | 271 | 263 | 314 | 381 | 440 | 568 | 601 | 744 | 833 | 828 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 215 | 183 | 161 | 218 | 142 | 182 | 113 | 225 | 308 | 369 | 449 |
Other Non-Current Liabilities | 151 | 151 | 173 | 196 | 160 | 133 | 216 | 285 | 357 | 286 | 298 |
Total Current Liabilities | 377 | 431 | 536 | 504 | 679 | 604 | 651 | 790 | 916 | 1233 | 1160 |
Total Liabilities | 998 | 1037 | 1134 | 1233 | 1362 | 1400 | 1617 | 1901 | 2325 | 2720 | 2734 |
Fixed Assets | 319 | 327 | 333 | 358 | 452 | 475 | 465 | 627 | 615 | 832 | 1126 |
Other Non-Current Assets | 163 | 138 | 155 | 192 | 166 | 108 | 202 | 355 | 622 | 514 | 277 |
Total Current Assets | 517 | 571 | 646 | 684 | 744 | 740 | 859 | 919 | 1089 | 1374 | 1303 |
Total Assets | 998 | 1037 | 1134 | 1233 | 1362 | 1400 | 1617 | 1901 | 2325 | 2720 | 2734 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 34 | 41 | 13 | 22 | 20 | 10 | 8 | 5 | 8 | 16 | 25 |
Cash Flow from Operating Activities | 25 | 48 | 112 | 164 | 163 | 148 | 71 | 263 | 165 | 180 | 287 |
Cash Flow from Investing Activities | -120 | -28 | -61 | -83 | -135 | -87 | -27 | -220 | -266 | -308 | -189 |
Cash Flow from Financing Activities | 101 | -48 | -43 | -81 | -38 | -62 | -48 | -39 | 108 | 138 | -103 |
Net Cash Inflow / Outflow | 7 | -27 | 8 | -0 | -10 | -2 | -3 | 3 | 8 | 9 | -5 |
Closing Cash & Cash Equivalent | 41 | 13 | 22 | 21 | 10 | 8 | 5 | 8 | 16 | 25 | 20 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 3.18 | 5.06 | 7.86 | 10.1 | 14.64 | 12.24 | 19.52 | 20.88 | 20.38 | 18.77 | 6.47 |
CEPS(Rs) | 6.99 | 10.37 | 13.91 | 17.05 | 20.33 | 19.45 | 28.65 | 31.58 | 32.88 | 31.67 | 22.97 |
DPS(Rs) | 2.5 | 3 | 1.75 | 3 | 3.5 | 3.5 | 6 | 6.3 | 6 | 5 | 1.5 |
Book NAV/Share(Rs) | 29.53 | 31.94 | 37.93 | 45.35 | 55.05 | 63.56 | 82.01 | 86.79 | 107.23 | 120.03 | 119.16 |
Core EBITDA Margin(%) | 8.44 | 10.91 | 9.93 | 11.18 | 13.53 | 13.83 | 12.96 | 14.55 | 15.02 | 12.63 | 9.26 |
EBIT Margin(%) | 6.41 | 8.17 | 8.54 | 8.94 | 11.29 | 10.35 | 13.82 | 11.52 | 11.29 | 8.8 | 4.51 |
Pre Tax Margin(%) | 2.76 | 4.61 | 5.45 | 6.53 | 9.15 | 8.53 | 12.6 | 10.56 | 10.21 | 7.78 | 2.6 |
PAT Margin (%) | 2.34 | 2.91 | 4.14 | 4.61 | 6.66 | 5.69 | 8.33 | 8.49 | 7.57 | 5.91 | 1.95 |
Cash Profit Margin (%) | 5.14 | 5.97 | 7.33 | 7.78 | 10.21 | 9.96 | 12.45 | 12.8 | 12.21 | 9.96 | 6.91 |
ROA(%) | 2.41 | 3.44 | 5.01 | 5.91 | 7.07 | 5.57 | 8.8 | 8.25 | 6.68 | 5.15 | 1.64 |
ROE(%) | 11.06 | 16.47 | 22.48 | 24.25 | 26.41 | 18.74 | 26.35 | 24.83 | 21.01 | 16.52 | 5.41 |
ROCE(%) | 10.73 | 15.1 | 16.54 | 18.84 | 19.99 | 16.61 | 24.38 | 19.35 | 17.13 | 12.87 | 6.29 |
Receivable days | 78.32 | 71.05 | 79.95 | 80.65 | 92.12 | 91.28 | 77.84 | 75.88 | 83.09 | 81.71 | 78.24 |
Inventory Days | 82.21 | 73.7 | 70.65 | 60.58 | 68.02 | 72.03 | 66.51 | 76.74 | 80.5 | 81.06 | 84.05 |
Payable days | 74.81 | 52.57 | 61.24 | 75.6 | 116.71 | 128.9 | 98.12 | 114.72 | 139.85 | 138.33 | 137.45 |
PER(x) | 9.9 | 10.05 | 10.2 | 9.38 | 23.84 | 35.85 | 17.68 | 17.92 | 25.46 | 27.71 | 60.33 |
Price/Book(x) | 1.07 | 1.59 | 2.11 | 2.09 | 6.34 | 6.9 | 4.21 | 4.31 | 4.84 | 4.33 | 3.27 |
Dividend Yield(%) | 3.97 | 2.95 | 2.18 | 3.17 | 1 | 0.8 | 1.74 | 1.68 | 1.16 | 0.96 | 0.38 |
EV/Net Sales(x) | 0.7 | 0.69 | 0.79 | 0.75 | 2.21 | 2.6 | 1.72 | 1.8 | 2.24 | 1.99 | 1.52 |
EV/Core EBITDA(x) | 7.04 | 5.75 | 6.26 | 5.77 | 13.85 | 17.48 | 12.87 | 12.14 | 14.08 | 15.49 | 16 |
Net Sales Growth(%) | 9.07 | 28.15 | 8.9 | 15.69 | -9.06 | -11.33 | 19.83 | 7.23 | 9.1 | 18.06 | 4.59 |
EBIT Growth(%) | -15.2 | 62.96 | 14.1 | 20.78 | 14.85 | -18.03 | 57.33 | -10.59 | 7.39 | -7.96 | -46.43 |
PAT Growth(%) | -34.42 | 59.21 | 55.16 | 28.57 | 31.25 | -24.11 | 72.59 | 9.29 | -2.37 | -7.9 | -65.55 |
EPS Growth(%) | -34.42 | 59.21 | 55.16 | 28.57 | 44.97 | -16.41 | 59.46 | 6.98 | -2.37 | -7.9 | -65.55 |
Debt/Equity(x) | 2.14 | 1.99 | 1.65 | 1.37 | 1.14 | 0.98 | 0.65 | 0.83 | 0.83 | 0.99 | 0.99 |
Current Ratio(x) | 1.37 | 1.32 | 1.2 | 1.36 | 1.1 | 1.22 | 1.32 | 1.16 | 1.19 | 1.11 | 1.12 |
Quick Ratio(x) | 0.77 | 0.73 | 0.74 | 0.85 | 0.71 | 0.77 | 0.85 | 0.64 | 0.74 | 0.66 | 0.7 |
Interest Cover(x) | 1.76 | 2.29 | 2.76 | 3.71 | 5.27 | 5.68 | 11.34 | 12 | 10.47 | 8.57 | 2.36 |
Total Debt/Mcap(x) | 2 | 1.25 | 0.78 | 0.66 | 0.18 | 0.14 | 0.15 | 0.19 | 0.17 | 0.23 | 0.3 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 35.73 | 35.82 | 35.82 | 35.82 | 35.82 | 35.82 | 35.82 | 35.82 | 35.82 | 33.22 |
FII | 8.48 | 7.92 | 6.02 | 4.15 | 2.8 | 3.11 | 3.48 | 4.64 | 4.2 | 4.49 |
DII | 10.93 | 11.55 | 13.02 | 14.18 | 14.34 | 14.19 | 14.29 | 13.68 | 13.6 | 17.49 |
Public | 44.86 | 44.71 | 45.14 | 45.85 | 47.05 | 46.88 | 46.41 | 45.86 | 46.37 | 44.8 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 2.47 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.3 |
FII | 0.59 | 0.55 | 0.42 | 0.29 | 0.19 | 0.22 | 0.24 | 0.32 | 0.29 | 0.31 |
DII | 0.76 | 0.8 | 0.9 | 0.98 | 0.99 | 0.98 | 0.99 | 0.95 | 0.94 | 1.21 |
Public | 3.11 | 3.1 | 3.12 | 3.17 | 3.26 | 3.25 | 3.21 | 3.17 | 3.21 | 3.1 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6.92 | 6.92 | 6.92 | 6.92 | 6.92 | 6.92 | 6.92 | 6.92 | 6.92 | 6.92 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About